Matt LimbCOVID-19Study: Age-related differences in nasal cells offer COVID-19 protectionKey differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus may explain why children typically experience milder symptoms of COVID-19, say researchers.April 29, 2024FDA ClearancePillar Biosciences gets FDA approval for NGS solid tumor profiling testPillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.April 26, 2024SequencingMission Bio launches new features for Tapestri platformMission Bio has launched new multiplexing features for its Tapestri platform, saying they will make single-cell technology more affordable and accessible to the biomedical community.April 24, 2024Neurodegenerative DiseaseTarget ALS launches new data portal for researchA nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).April 23, 2024SequencingLabcorp expands precision oncology offeringsLaboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.April 12, 2024Neurodegenerative DiseaseSkin biopsy test shows promise for detection of neurogenerative diseasesA simple skin biopsy test has shown a high accuracy rate in detecting an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson's disease and other synucleinopathies, say neurologists.April 5, 2024Lung CancerU.K. researchers get funding for lung cancer vaccine developmentResearchers are working to develop a lung cancer vaccine in the U.K. with 1.7 million pounds ($2.2 million) funding from leading charities.April 4, 2024Neurodegenerative DiseaseU.K. team develops new approach to detect signs of motor neuron diseaseScientists have identified a new way to detect signs of motor neuron disease (MND) in brain tissue, raising hopes for early diagnosis and intervention before onset of symptoms.April 3, 2024CancerStudy sheds light on the organization of immune cells in tumorsResearchers have revealed how immune cells are spatially organized within some tumors and that certain immune “hubs” may be linked to better cancer treatment responses.March 27, 2024Artificial IntelligenceIbex presents new study data for AI-powered cancer diagnostics platformIbex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.March 26, 2024Page 1 of 9Next PageTop StoriesMonkeypoxSeegene launches 3rd RUO mpox assayAfter introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.Policy and RegulationHospital labs targeted in proposed Calif. hospital licensing regulationsResearch GrantHudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencingClinical ChemistryADLM releases guidance for blood lipid assessment, lipoprotein testingSponsor ContentVisit our Molecular Diagnostics Community
